Clinical Trials for Urogenital Neoplasms

Find clinical trials for urogenital neoplasms. Discover research opportunities and treatment options in your area.

13 Active Trials Found

Showing 13 trials on this page

Page 1 of 1

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

NCT ID: NCT04235777

This clinical trial is studying two new drugs, M7824 and M9241, to see if they can help the immune system fight certain types of cancer that have spread to other parts of the body, specifically can...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT ID: NCT04923178

This clinical trial is looking to learn more about urinary tract cancers, including those that are common, like bladder cancer, as well as rarer types that can affect the kidney, prostate, and test...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Washington, District Of Columbia, United States +1 more

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

NCT ID: NCT06785636

This clinical trial is looking at a new treatment option for men with metastatic castration-resistant prostate cancer (mCRPC), which is a type of advanced prostate cancer that no longer responds to...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Houston, Texas, United States +5 more

Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma

NCT ID: NCT06738797

This clinical trial is studying a new way to predict how well patients with advanced bladder cancer might respond to a type of treatment called checkpoint inhibitors, which are a form of immunother...

Recruiting

Type: observational Locations: Nice, , France, Nimes, , France +3 more

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

NCT ID: NCT05413850

This clinical trial is studying a treatment called 177Lu-rhPSMA-10.1 injection for men with advanced prostate cancer that has continued to grow despite other treatments. The main goals of the study...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Saint Louis, Missouri, United States +5 more

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT ID: NCT06237920

This clinical trial is looking at new treatment options for patients with Stage II-IIIa urothelial cancer, which is a type of bladder cancer. The study is comparing two treatment approaches: one gr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Utrecht, , Netherlands, Amsterdam, Noord Holland, Netherlands +5 more

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT ID: NCT05592626

This clinical trial is testing a new treatment called STAR0602, which is a special type of antibody designed to target certain solid tumors in patients whose cancer has advanced and cannot be treat...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Miami, Florida, United States +11 more

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

NCT ID: NCT06706921

This clinical trial is studying how a specific imaging test called 18F-Fluciclovine PET/CT can help predict how well a treatment called Lutetium-PSMA-617 therapy works for men with advanced prostat...

Recruiting

Phase: PHASE4 Type: interventional Locations: Los Angeles, California, United States

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

NCT ID: NCT05887245

This clinical trial is studying a condition called adherent perinephric fat (APF) in patients who are undergoing a type of kidney surgery known as partial nephrectomy. APF is a type of fat that sti...

Recruiting

Type: observational Locations: Otwock, , Poland

CD70-targeted immunoPET Imaging of Kidney Cancer

NCT ID: NCT06680089

This clinical trial is studying a new imaging method called \[18F\]RCCB6 PET/CT to help diagnose kidney cancer, particularly a type known as clear cell renal cell carcinoma. The goal is to see how ...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Vorolanib in the Second-line Treatment of Patients with Unresectable or Metastatic Renal Cell Carcinoma

NCT ID: NCT06676527

This clinical trial is investigating the effectiveness of a medication called vorolanib for patients with advanced kidney cancer that cannot be surgically removed or has spread to other parts of th...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

NCT ID: NCT06353906

This clinical trial is looking at the effectiveness of a combination treatment involving chemotherapy and immunotherapy for men with a specific type of advanced penile cancer known as squamous cell...

Recruiting

Phase: PHASE2 Type: interventional Locations: Amsterdam, Noord Holland, Netherlands

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

NCT ID: NCT04519151

This clinical trial is studying the effects of two medications, pembrolizumab (also known as KEYTRUDA®) and lenvatinib, for women with platinum-sensitive recurrent ovarian cancer, which means their...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ramat Gan, , Israel

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions